CoChat
Sign Up
Cited by 223

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation

Forrest, A R R, Kanamori-Katayama, M, Tomaru, Y, Lassmann, T, Ninomiya, N, Takahashi, Y, de Hoon, M J L, Kubosaki, A, Kaiho, A, Suzuki, M, Yasuda, J, Kawai, J, Hayashizaki, Y, Hume, D A, Suzuki, H·2010·Leukemia
DOI 10.1038/leu.2009.246
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/leu.2009.246

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 50

  1. Suzuki H, Forrest AR, van Nimwegen E, Daub CO, Balwierz PJ, Irvine KM et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet 2009; 41: 553–562. · DOI · Paper page
  2. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K . Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171–176. · DOI
  3. Odero MD, Zeleznik-Le NJ, Chinwalla V, Rowley JD . Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation. Genes Chromosomes Cancer 2000; 29: 333–338. · DOI
  4. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42: 1530–1536.
  5. Standart N, Jackson RJ . MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation. Genes Dev 2007; 21: 1975–1982. · DOI
  6. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228–233. · DOI
  7. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279: 52361–52365. · DOI
  8. Hohjoh H, Fukushima T . Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells. Biochem Biophys Res Commun 2007; 362: 360–367. · DOI
  9. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 2005; 19: 489–501. · DOI
  10. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215–217. · DOI · Paper page
  11. O’Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 2007; 21: 1999–2004. · DOI
  12. Lee YS, Dutta A . The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21: 1025–1030. · DOI
  13. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H . Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472–15477. · DOI
  14. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628–9632. · DOI
  15. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243–249. · DOI
  16. Severin J, Waterhouse AM, Kawaji H, Lassmann T, van Nimwegen E, Balwierz PJ et al. FANTOM4 EdgeExpressDB: an integrated database of promoters, genes, microRNAs, expression dynamics and regulatory interactions. Genome Biol 2009; 10: R39. · DOI
  17. Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M et al. The interplay between the master transcription factor PU 1 and miR 424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 2007; 104: 19849–19854. · DOI · Paper page
  18. Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD et al. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008; 111: 588–595. · DOI
  19. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102: 18081–18086. · DOI · Paper page
  20. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103: 7024–7029. · DOI
  21. Georgantas 3rd RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007; 104: 2750–2755. · DOI
  22. Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kanesaki Y, Suda T et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 2009; 583: 2263–2268. · DOI
  23. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH et al. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242–252. · DOI
  24. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007; 9: 775–787. · DOI · Paper page
  25. Taft RJ, Glazov EA, Cloonan N, Simons C, Stephen S, Faulkner GJ et al. Tiny RNAs associated with transcription start sites in animals. Nat Genet 2009; 41: 572–578. · DOI
  26. Smyth GK, Yang YH, Speed T . Statistical issues in cDNA microarray data analysis. Methods Mol Biol 2003; 224: 111–136.
  27. Beissbarth T, Speed TP . GOstat: find statistically overrepresented gene ontologies within a group of genes. Bioinformatics 2004; 20: 1464–1465. · DOI
  28. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008; 36: 5391–5404. · DOI
  29. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944–13949. · DOI
  30. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793–1801. · DOI
  31. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27: 2240–2252. · DOI · Paper page
  32. Gaidatzis D, van Nimwegen E, Hausser J, Zavolan M . Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinformatics 2007; 8: 69. · DOI
  33. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB . Prediction of mammalian microRNA targets. Cell 2003; 115: 787–798. · DOI · Paper page
  34. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004; 2: E7. · DOI
  35. Martinez FO, Gordon S, Locati M, Mantovani A . Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303–7311. · DOI
  36. Martino V, Tonelli R, Montemurro L, Franzoni M, Marino F, Fazzina R et al. Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23). Oncol Rep 2006; 15: 207–211.
  37. Pession A, Martino V, Tonelli R, Beltramini C, Locatelli F, Biserni G et al. MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells. Oncogene 2003; 22: 8671–8676. · DOI
  38. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524–15529. · DOI · Paper page
  39. Kang S, Dong S, Gu TL, Guo A, Cohen MS, Lonial S et al. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway. Cancer Cell 2007; 12: 201–214. · DOI
  40. Liu D, Yang X, Songyang Z . Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr Biol 2000; 10: 1233–1236. · DOI
  41. Basso AD, Mirza A, Liu G, Long BJ, Bishop WR, Kirschmeier P . The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity. J Biol Chem 2005; 280: 31101–31108. · DOI
  42. Wang W, Wang CY, Dong JH, Chen X, Zhang M, Zhao G . Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette. World J Gastroenterol 2005; 11: 2026–2031. · DOI
  43. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007; 450: 1096–1099. · DOI
  44. O’Sullivan AW, Wang JH, Redmond HP . The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells. J Surg Res 2009; 151: 138–144. · DOI
  45. Astrinidis A, Senapedis W, Henske EP . Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. Hum Mol Genet 2006; 15: 287–297. · DOI
  46. Kitagawa K, Abdulle R, Bansal PK, Cagney G, Fields S, Hieter P . Requirement of Skp1-Bub1 interaction for kinetochore-mediated activation of the spindle checkpoint. Mol Cell 2003; 11: 1201–1213. · DOI
  47. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007; 26: 3699–3708. · DOI
  48. Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM et al. MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 2008; 68: 2773–2780. · DOI
  49. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007; 14: 791–798. · DOI
  50. Mayoral RJ, Pipkin ME, Pachkov M, van Nimwegen E, Rao A, Monticelli S . MicroRNA-221-222 regulate the cell cycle in mast cells. J Immunol 2009; 182: 433–445. · DOI

Cited by

Sorted by citations

Metadata

Authors
Forrest, A. R. R., Kanamori-Katayama, M., Tomaru, Y., Lassmann, T., Ninomiya, N., Takahashi, Y., de Hoon, M. J. L., Kubosaki, A., Kaiho, A., Suzuki, M., Yasuda, J., Kawai, J., Hayashizaki, Y., Hume, D. A., & Suzuki, H.
Venue
Leukemia
Publisher
Springer Science and Business Media LLC
Published
2009-12-03
Volume
24
Issue
2
Pages
460-466
ISSN
  • 0887-6924
  • 1476-5551
DOI
10.1038/leu.2009.246
Cited by
223
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review